Back to Search
RENE GELBER, M.D.
M.D.
Surgery Physician
NPI: 1376513390Individual
Specialties, Licenses & Credentials
Vascular Surgery Physician
Surgery — Vascular Surgery
Code: 2086S0129X
D0017502(MD)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
D0017502(MD)
Research & Publications (20)
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
PMID 19280340·Breast Cancer Res Treat·2010
4-observational
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
PMID 19633051·Ann Oncol·2010
4-observational
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
PMID 19528136·Clin Trials·2009
3-trial
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
PMID 19535820·Ann Oncol·2009
8-other
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
PMID 19573224·BMC Med Genomics·2009
8-other
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.
PMID 19487378·J Clin Oncol·2009
3-trial
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
PMID 19062268·Eur J Cancer·2009
3-trial
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
PMID 19468030·Ann Oncol·2009
4-observational
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.
PMID 19364966·J Clin Oncol·2009
3-trial
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
PMID 19137426·Breast Cancer Res Treat·2009
8-other
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
PMID 19243946·Breast·2009
2-rct
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.
PMID 19170050·Stat Med·2009
8-other
A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
PMID 19635893·Am J Trop Med Hyg·2009
2-rct
Population-based molecular epidemiology of leprosy in Cebu, Philippines.
PMID 19571027·J Clin Microbiol·2009
8-other
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
PMID 19484813·N Engl J Med·2009
8-other
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
PMID 18953651·Breast Cancer Res Treat·2009
4-observational
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
PMID 18941889·Breast Cancer Res Treat·2009
3-trial
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
PMID 18259856·Breast Cancer Res Treat·2009
4-observational
The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently.
PMID 19596891·Antimicrob Agents Chemother·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14201 LAUREL PARK DR, SUITE 223
LAUREL, MD 20707 - Phone
- (301) 490-6098
Quick Facts
- NPI
- 1376513390
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile